Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Guilleminault, F. Paul, S. Lerondel, V. Schubnel, J. Montharu, M. De Monte, A. Lepape, E. Lemarié, N. Heuzé-Vourc'h (Tours, Orléans, France). Cetuximab administered through pulmonary route in a mice model of lung tumor. Eur Respir J 2013; 42: Suppl. 57, 370

Member's Comments

No comment yet.

Related content which might interest you: Electrospray-mediated local chemotherapy of lung carcinoma in mice Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Gefitinib versus erlotinib as first-line treatment in EGFR mutant advanced lung adenocarcinoma Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Lung adenocarcinoma mimicking interstitial lung disease showed good response to navelbine monotherapy Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Chemopreventive effect of phosphodieasterase-4 inhibition in benzo(a)pyrene-induced murine lung cancer model Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Approach to hypersensitivity reactions to chemotherapeutics in patients with lung cancer Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Effect of 17-oxo-DHA alone and in combination with gemcitabine on lung cancer cell growth Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Primary lung cancer treated using radiofrequency ablation: Two year outcome data Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Functional impairment of NK cells in non-small-cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 The value of miR221 and miR222 as a biomarker in non small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Significance of age, tumor location and histological subtype in lung cancer with brain metastasis Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013